{"transactions":[{"id":1382171,"issuer":{"id":7759,"kind":"organization","name":"FIREFLY NEUROSCIENCE, INC.","symbol":"AIFF"},"owners":[{"id":71179,"kind":"person","name":"Johnson David Ian","position":1,"cik":"0001563432","reported_name":"Johnson David Ian","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-10-24T20:07:29.000Z","date":"2024-10-22","kind":"grant","planned":false,"acquired":true,"shares":557885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person was granted the shares of restricted common stock pursuant to that certain Employment Agreement, by and between Firefly Neuroscience, Inc. and the reporting person. One-half the shares shall vest on each of the sixth and twelfth month anniversaries of the grant date, provided that the reporting person has not incurred a termination of service prior to the applicable vesting date."}],"balance_after":557885,"source":{"system":"sec-edgar","filing":"0001437749-24-032018","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/803578/000143774924032018/rdgdoc.xml","form_type":"4"}},{"id":2856182,"issuer":{"id":8193,"kind":"organization","name":"Enveric Biosciences, Inc."},"owners":[{"id":71179,"kind":"person","name":"Johnson David Ian","position":1,"cik":"0001563432","reported_name":"Johnson David Ian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Restricted Stock Units","published_at":"2021-02-18T00:29:29.000Z","date":"2021-02-15","kind":"grant","acquired":true,"shares":53192,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents restricted stock units granted to the reporting person pursuant to the Enveric Biosciences, Inc. (the \"Company\") 2020 Long-Term Incentive Plan (the \"Plan\"). For each vested restricted stock unit, the reporting person will be entitled to receive one share of common stock upon termination of employment with or services to the Company or in connection with a change of control, as set forth in the reporting person's restricted stock unit award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest in tranches based on the achievement of certain Company and individual performance goals in the 2021 calendar year established by the compensation committee of the board of directors of the Company for each such tranche and as set forth in the reporting person's restricted stock unit award agreement, provided the reporting person is employed by or providing services to the Company through the applicable vesting date, and subject to certain restrictions and conditions set forth in the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest in tranches based on the achievement of certain Company and individual performance goals in the 2021 calendar year established by the compensation committee of the board of directors of the Company for each such tranche and as set forth in the reporting person's restricted stock unit award agreement, provided the reporting person is employed by or providing services to the Company through the applicable vesting date, and subject to certain restrictions and conditions set forth in the Plan."}],"balance_after":1368999,"derivative":{"underlying":"Common Stock","underlying_shares":53192},"source":{"system":"sec-edgar","filing":"0001493152-21-004174","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/890821/000149315221004174/ownership.xml","form_type":"4"}},{"id":2856181,"issuer":{"id":8193,"kind":"organization","name":"Enveric Biosciences, Inc."},"owners":[{"id":71179,"kind":"person","name":"Johnson David Ian","position":1,"cik":"0001563432","reported_name":"Johnson David Ian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Restricted Stock Units","published_at":"2021-02-18T00:29:29.000Z","date":"2021-02-15","kind":"grant","acquired":true,"shares":1315807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents restricted stock units granted to the reporting person pursuant to the Enveric Biosciences, Inc. (the \"Company\") 2020 Long-Term Incentive Plan (the \"Plan\"). For each vested restricted stock unit, the reporting person will be entitled to receive one share of common stock upon termination of employment with or services to the Company or in connection with a change of control, as set forth in the reporting person's restricted stock unit award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third (1/3rd) of the restricted stock units vested as of December 30, 2020, and the remaining two-thirds (2/3rds) of the restricted stock units shall vest in three equal tranches, with the vesting of each tranche based on the achievement of a performance milestone established by the compensation committee of the board of directors of the Company for such tranche and as set forth in the reporting person's restricted stock unit award agreement, provided the reporting person is employed by or providing services to the Company through the applicable vesting date, and subject to certain restrictions and conditions set forth in the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"One-third (1/3rd) of the restricted stock units vested as of December 30, 2020, and the remaining two-thirds (2/3rds) of the restricted stock units shall vest in three equal tranches, with the vesting of each tranche based on the achievement of a performance milestone established by the compensation committee of the board of directors of the Company for such tranche and as set forth in the reporting person's restricted stock unit award agreement, provided the reporting person is employed by or providing services to the Company through the applicable vesting date, and subject to certain restrictions and conditions set forth in the Plan."}],"balance_after":1315807,"derivative":{"underlying":"Common Stock","underlying_shares":1315807},"source":{"system":"sec-edgar","filing":"0001493152-21-004174","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/890821/000149315221004174/ownership.xml","form_type":"4"}},{"id":4270381,"issuer":{"id":155807,"kind":"organization","name":"Adynxx, Inc.","symbol":"ADYX"},"owners":[{"id":71179,"kind":"person","name":"Johnson David Ian","position":1,"cik":"0001563432","reported_name":"Johnson David Ian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-06-29T12:54:54.000Z","date":"2017-06-28","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock award that is subject to forfeiture until vested. The award vests fully on the date, if any, the Issuer files financial statements with the SEC on Form 10-K or Form 10-Q that report a positive adjusted EBITDA for the Company for two consecutive fiscal quarters, subject to the Reporting Person's continued service through the applicable vesting date and the terms and conditions of the Alliqua BioMedical, Inc. 2014 Long-Term Incentive Plan and that certain restricted stock award agreement by and between the Issuer and the Reporting Person, effective as of June 28, 2017."}],"balance_after":1994535,"source":{"system":"sec-edgar","filing":"0001144204-17-034809","document":"v469950_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1054274/000114420417034809/v469950_4.xml","form_type":"4"}},{"id":4272757,"issuer":{"id":155807,"kind":"organization","name":"Adynxx, Inc.","symbol":"ADYX"},"owners":[{"id":71179,"kind":"person","name":"Johnson David Ian","position":1,"cik":"0001563432","reported_name":"Johnson David Ian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-06-26T17:01:16.000Z","date":"2017-06-23","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the Reporting Person's 2016 year-end bonus paid in shares of restricted stock in lieu of cash based on the value of the Issuer's common stock on February 27, 2017. This award is subject to forfeiture until vested, with 100% vesting on June 23, 2018, subject to the Reporting Person's continued service through the applicable vesting date and the terms and conditions of the Alliqua BioMedical, Inc. 2014 Long-Term Incentive Plan and that certain restricted stock award agreement by and between the Issuer and the Reporting Person, effective as of June 23, 2017."}],"balance_after":1694535,"source":{"system":"sec-edgar","filing":"0001144204-17-034085","document":"v469570_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1054274/000114420417034085/v469570_4.xml","form_type":"4"}},{"id":4362193,"issuer":{"id":155807,"kind":"organization","name":"Adynxx, Inc.","symbol":"ADYX"},"owners":[{"id":71179,"kind":"person","name":"Johnson David Ian","position":1,"cik":"0001563432","reported_name":"Johnson David Ian","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-04-04T09:00:54.000Z","date":"2017-04-03","kind":"purchase","acquired":true,"shares":250000,"price":0.4,"value":100000.0,"ownership":{"direct":true},"balance_after":1194535,"source":{"system":"sec-edgar","filing":"0001144204-17-018721","document":"v463366_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1054274/000114420417018721/v463366_4.xml","form_type":"4"}}]}